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ADENOSINE TRIPHOSPHATE- 
SENSITIVE K + CHANNELS 
MEDIATE 
POSTCARDIOPLEGIA 
CORONARY HYPEREMIA 
The purpose of the present study was to examine the role of adenosine 
triphosphate-sensitive potassium channels in mediating the coronary hy- 
peremic response after crystalloid cardioplegia. Thirteen pigs were placed 
on normothermic cardiopulmonary b pass support. Hearts were arrested 
with cold (4* C) crystalloid ([K +] 25 mmol/L) cardioplegic solution for 60 
minutes. In seven of these pigs, hearts were then reperfused for 60 minutes 
with warm blood, and the animal was separated from cardiopulmonary 
bypass. The in vivo responses to the intracoronary administration ofthe K + 
adenosine triphosphate channel blocker glibenclamide (50 gm/kg per 
minute) or the K + adenosine triphosphate channel opener pinacidil (2 
gm/kg per minute) were evaluated before cardiopulmonary b pass (base- 
line) and after 2 minutes and 60 minutes of reperfusion i  the cardioplegia- 
reperfusion group. Under baseline conditions, glibenclamide and pinacidil 
induced a respective decrease and increase in coronary blood flow and an 
increase and a decrease in coronary vasculai" resistance. Coronary re- 
sponses to glibenclamide and pinacidil were markedly enhanced after 2 
minutes or 60 minutes of postcardioplegia reperfusion. In vitro responses 
of coronary arterioles (90 to 180 /xm) were examined in a pressurized, 
no-flow state with video microscopy. The contractile response of coronary 
arterioles to glibenclamide and the relaxation response to pinacidil were 
significantly enhanced 2 minutes or 60 minutes after reperfusion (all p < 
0.05 versus control). The response to pinacidil was markedly inhibited by 
glibenclamide, which confirms these antagonistic effects on K + adenosine 
triphosphate channels. Decreased tissue concentrations of adenosine 
triphosphate in the coronary arterial smooth muscle and myocardium were 
observed after cardioplegia nd persisted for up to 60 minutes of reperfu- 
sion (both p < 0.05 versus control). These results suggest hat coronary 
hyperemia ssociated with postischemic cardioplegia is mediated in part by 
activation of K + adenosine triphosphate channels in the coronary micro- 
circulation. (J THORAC CARDIOVASC SURG 1995;110:1073-82) 
Steven Y. Wang, MD, PhD, Menachem Friedman, MD, 
Robert G. Johnson, MD, Adib J. Zeind, MS, and Frank W. Sellke, MD, 
Boston, Mass. 
A growing body of evidence suggests that adeno- 
sine triphosphate-sensitive potassium (K+ATP) 
channels contribute to the regulation of coronary 
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vascular tone. The opening of K+ATP channels 
induces hyperpolarization and relaxes the vascular 
smooth muscle by a reduction in Ca ++ influx. Daut 
and associates 1 have demonstrated that blockade of 
K+ATP channels abolishes coronary vasodilation in- 
duced by hypoxia in the isolated heart of guinea 
pigs. The K+aa.v channel blocker glibenclamide also 
has been shown to inhibit hyperemic response to 
brief coronary occlusion in the canine coronary 
circulation? In addition, a number of investigations 
have showed that activation of K+ATP channels 
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mediates dilation of cerebral arterioles 3 and renal 
afferent arterioles 4 during hypoxia. Thus K÷ATP 
channels contribute importantly to the control of 
blood flow in hypoxia or in ischemic settings, or in 
both. 
Reactive coronary hyperemia is a phenomenon 
frequently observed uring the postcardioplegia pe- 
riod. The mechanism underlying this hyperemic 
response has not been defined, although it may 
involve the local release of metabolic vasodilators 
such as adenosine, prostaglandins, nitric oxide, and 
alterations in myogenic reactivity of coronary arte- 
rioles. 5"8 However, the role of K+ATP channels in 
mediating coronary hyperemic response after hy- 
perkalemic crystalloid cardioplegia has not been 
characterized. Adenosine has been suggested to 
activate K+ATp channels9; however, the role of 
adenosine in the activation of K+ATp channels dur- 
ing coronary hyperemia ssociated with crystalloid 
cardioplegia is undefined. Consequently, the present 
study was designed to examine in vivo and in vitro 
coronary microvascular esponses in a clinically 
applicable model of extracorporeal circulation and 
cold, hyperkalemic ardioplegia. We hypothesized 
that reactive coronary hyperemia associated with 
postischemic ardioplegia is mediated, at least in 
part, by activation of K+ATP channels in the coro- 
nary microcirculation. 
Methods 
Animal preparation. Yorkshire pigs (18 to 22 kg) of 
either sex were premedicated with ketamine (10 mg/kg, 
intramuscularly) and anesthetized with a-chloralose and 
urethane (respectively 60 mg/kg and 300 mg/kg intrave- 
nously initially and 15 mg/kg and 60 mg/kg every 60 
minutes as needed). Pigs were tracheally intubated and 
the lungs mechanically ventilated. In the control group 
(n = 7), a sternotomy was performed and the animal was 
heparinized (500 units/kg). The heart was rapidly excised 
and immediately placed in cold (5 ° to 10 ° C) 3-[N-mor- 
pholino]propanesulfonic acid (MOPS) buffer solution of 
the following composition (in millimoles per liter): 
NaCL 145.0, KCL 4.7, CaCL 2 2.0, MgSO 4 1.2, glucose 
5.0, pyruvate 2.0, ethylenediaminetetraacetic acid 0.02, 
NaH2PO 4 1.2, and MOPS 3.0. 
Cardioplegia group. In six pigs, after approximately 15
minutes of cardiopulmonary bypass (CPB), an aortic 
crossclamp was placed and 300 ml of cold (4 ° C) crystal- 
loid, hyperkalemic ([K +] 25 mmol/L) cardioplegic solu- 
tion was infused into the aortic root at a pressure of 60 
mm Hg. The composition of the crystalloid cardioplegic 
solution was (in millimoles) NaCL 121, KCL 25, NaHCO 3 
12, and glucose 11.1; pH 7.6, oxygen tension 160 to 260 
mm Hg. Saline slush was placed on the surface of the 
heart to provide topical hypothermia during the cross- 
clamp period. At no time did the heart fibrillate during the 
ischemic ardioplegic period. Myocardial temperature of
the anterior left ventricular wall was measured with a 
probe and ranged from 6 ° C to 14 ° C during the period of 
cardioplegia. Infusion of the cardioplegic solution (150 
ml) was repeated at 20-minute intervals for 60 minutes 
(two additional doses) during which time CPB was con- 
tinued. After 60 minutes of cardioplegic arrest, the heart 
was rapidly excised and immediately placed in cold (1 ° to 
4 ° C) MOPS buffer solution. 
Reperfusion group. In seven pigs, the same procedure 
was performed as in the cardioplegia group. However, 
after 60 minutes of cardioplegic arrest, the aortic cross- 
clamp was removed and the heart was reperfused with 
normothermic blood from the bypass circuit. The heart 
was kept decompressed with a left ventricular vent placed 
through the left ventricular apex until a stable rhythm was 
obtained. In the case of ventricular fibrillation, the heart 
was defibrillated with 10 joules after the myocardial 
temperature ose to greater than 30 ° C. Pigs were weaned 
from CPB shortly after release of the aortic crossclamp 
when arterial pressure and cardiac rhythm became stable, 
and the pigs were then decannulated. During the reper- 
fusion period, mean arterial pressure was maintained 
between 50 and 70 mm Hg. After 60 minutes of reperfu- 
sion, the heart was rapidly excised and immediately placed 
in cold MOPS buffer solution. 
In vivo studies. In vivo responses to glibenclamide were 
studied in six pigs from the cardioplegia-reperfusion 
group. An 8F micromanometer-tipped catheter (Millar 
Instruments, Inc., Houston, Tex.) was inserted from the 
left ventricular apex into the left ventricular cavity. Left 
ventricular rate of pressure rise (dP/dt) was derived by 
differentiating left ventricular pressure signal over time. 
For intracoronary isoproterenol administration, a silicone 
rubber catheter (inner diameter 0.3 mm, outer diameter 
0.5 mm) was introduced into the proximal eft anterior 
descending (LAD) coronary artery according to a method 
similar to that described by Hard and Barger. m Coronary 
blood flow was measured with an ultrasonic flow probe 
(Transonic System Inc., Ithaca, N.Y.) that was placed 
around the LAD coronary artery distal to the point of the 
cannulation for intracoronary drug administration. A pair 
of ultrasonic rystals was implanted in the left ventricular 
subendocardium perfused by the LAD branches. The 
crystals were placed parallel to the short axis of the left 
ventricle. Percent systolic shortening was calculated as 
follows: (end-diastolic segment length - end-systolic seg- 
ment length/end-diastolic segment length) × 100. 
In vivo responses to the intracoronary administration f
glibenclamide and pinacidil were studied before initiation 
of CPB and after 2 minutes and 60 minutes of postcar- 
dioplegia reperfusion. Intracoronary administration of 
pinacidil was given at 2 /zg/kg per minute (volume 0.6 
ml/min) with the use of a miniature pump (Living System 
Instrumentation, Burlington, Vt.). Changes in coronary 
blood flow in response to pinacidil administration usually 
returned to the baseline level within 5 minutes after 
termination of the drug administration. An additional 15 
minutes was then allowed for stabilization and washout. 
Glibenclamide at 50/zg/kg per minute was then adminis- 
tered by the intracoronary route. All pressure and flow 
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signals were recorded on an eight-channel recorder (Hon- 
eywell-Electronics for Medicine Research, Natick, Mass.). 
In two pigs, vehicle without glibenclamide or pinacidil 
was administered at the same rate (0.6 ml/min) as that 
during drug administration. The vehicle caused a minimal 
increase (approximately 4%) in coronary blood flow and 
had no effects on cardiac functional parameters. 
In vitro coronary microvessel studies. Subepicardial 
coronary arterioles were dissected from the left ventricu- 
lar myocardium perfused by LAD branches with use of a 
x 10 to ×60 dissecting microscope (Olympus Optical Co., 
Ltd., Tokyo, Japan). Microvessels were placed in an 
isolated Plexiglas acrylic plastic organ chamber, cannu- 
lated with dual glass micropipettes measuring 30 to 80/xm 
in diameter and secured with 10-0 nylon monofilament 
suture (Ethicon, Inc., Somerville, N.J.). Both ends of 
micropipettes were connected to a pressure reservoir so 
that intraluminal pressure could be varied by adjusting the 
height of the reservoir. The pressure was measured by a 
burette manometer connected to the micropipettes. 
MOPS buffer solution (pH 7.4) equilibrated with room air 
was continuously circulated through the organ chamber 
and a reservoir (total volume 100 ml). The solution was 
warmed to 37 ° C by an external heat exchanger. With an 
inverted microscope (x40 to x200 magnification, Olym- 
pus Optical Co., Ltd., Tokyo, Japan) connected to a video 
camera, the vessel image was projected onto a black-and- 
white television monitor (Hitachi Denshi Ltd., Taiwan). 
An electronic dimension analyzer (Living System Instru- 
mentation) was used to measure internal lumen diameter. 
Measurements were recorded with a strip chart recorder 
(Graphtec, Irvine, Calif.). 
In all experimental groups, relaxation responses to 
pinacidil, adenosine, and sodium nitroprusside were ex- 
amined after precontraction of microvessels. Acetylcho- 
line was used to precontract the microvessels because it 
induces the contractile response in the porcine coronary 
microvessel without releasing endothelium-derived r lax- 
ation factor, it Once the steady-state one was reached, 
responses to pinacidil (10 -9 to 10 -4 mol/L), adenosine 
(10 -9 to 10-4mol/L), or sodium nitroprusside (10 -9 to 
10 -4 tool/L) were examined. The contractile response to 
glibenclamide (10 5 mol/L) was determined in nonpre- 
contracted vessels. In addition, in noninstrumented con- 
trol animals, relaxation responses to pinacidil and adeno- 
sine were examined in vessels pretreated with 
glibenclamide (10 5 tool/L) at least 15 minutes before a 
dose-response intervention was done. One to three inter- 
ventions were done on each vessel. The order of drug 
administration was random. The dose response to pinaci- 
dil or adenosine was examined only once in each vessel to 
avoid tachyphylaxis. All drugs were applied extralumi- 
nally. Measurements were taken 2 to 3 minutes after the 
drug was administered, when the response had stabilized. 
The vessels were washed three times with MOPS buffer 
solution and allowed to equilibrate in a drug-free MOPS 
buffer solution for 10 to 15 minutes between experimental 
interventions. 
Biochemical assay. In control animals 01 = 4), and in 
animals after 2 minutes (n = 4) or 60 minutes (n = 4) of 
postcardioplegia reperfusion, the hearts were removed en 
bloc and placed in cold physiologic saline solution (4 ° C). 
The myocardial specimen was obtained from the subepi- 
cardial myocardium of the left ventricle perfused by the 
LAD branches. The vascular specimen was obtained from 
the distal LAD coronary artery, which was dissected free 
and was cut into small segments (approximately 1 cm in 
length). The endothelium was deliberately removed by 
gently rubbing the luminal surface with the tip of the 
forceps. The specimens were immediately placed in liquid 
nitrogen and maintained at -80°C until assay. The 
specimens were weighed and pulverized in a pestle kept in 
liquid nitrogen. The fragments were quickly dropped into 
a test tube filled with chloroform (2 ml) and methanol 
(1 ml) solution and kept in an ice bath. 12 After addition of 
1 ml mobile phase, the sample was homogenized at 2400 
rpm for 1 minute and was then centrifuged at 3000 rpm 
for 5 minutes to separate the layers. The top aqueous layer 
was transferred to another test tube and the extraction 
was repeated using mobile phase (1 ml). The sample was 
then combined with the water layer and stored at -80  ° C 
until analysis. The high-performance liquid chromatogra- 
phy method was used to measure ATP according to the 
method similar to that described by Stocchi and col- 
leagues. 13 The blank, standard, sample, and recovery 
spikes were all analyzed under the same conditions. The 
recovery of the nucleotide was between 88% and 96%. 
The analytic column was 25 cm in length (Bondapak, 
C-18, Water, Milford, Mass.). The mobile phase consisted 
of potassium dihydrogen phosphate (0.07 mol/L), tetrabu- 
tylammonium (0.004 tool/L), methanol (13%), and water 
(87%) (pH 5.65). The results were expressed as micro- 
grams per gram wet weight of tissue. 
Drugs. Glibenclamide, adenosine, sodium nitroprus- 
side, acetylcholine, and sodium nitroprusside were ob- 
tained from Sigma Chemical Co. (St. Louis, Mo.). Pin- 
acidil was obtained from Research Biochemical 
International (Natick, Mass.). Glibenclamide was dis- 
solved in dimethyl sulfoxide (2%) and saline to which 
sodium bicarbonate was added to adjust the pH to 8.5. 
Pinacidil was dissolved in dimethyl sulfoxide (2%) and 
saline solution. Other drugs were dissolved in ultrapure 
distilled water. All solutions were prepared on the day of 
the study. 
Data analysis. The response of microvessels to each 
agent was examined only once in each animal. Therefore 
each animal served as one sample. The data were pooled 
from each dose response in each experimental group and 
an average was calculated. Relaxation responses were 
expressed as percent relaxation of the acetylcholine-in- 
duced precontraction f the vessel diameter. Values were 
expressed as mean plus or minus the standard error of 
mean. The paired Student's t test was used to compare 
changes in hemodynamic variables in response to in vivo 
glibenclamide or pinacidil administration. The in vitro 
contractile responses to glibenclamide and ATP concen- 
trations in all experimental groups were compared by 
two-way analysis of variance with factorial design and 
Scheffe's post hoc test for multiple comparisons. Com- 
parisons of in vitro dose responses of all experimental 
groups were done with two-way analysis of variance 
with repeated-measure d sign and Scheffe's post hoc 
test. A p value of less than 0.05 was considered to be 
significant. 
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Fig. 1. Changes in coronary blood flow in response to 
intracoronary pinacidil administration under baseline 
condition (PRE-BYPASS) and after 2 minutes (POST- 
CARDIOPLEGIA, n = 6) and 60 minutes of reperfusion 
(POST-REPERFUSION, n = 7). *p < 0.05; **p < 0.01 
versus respective baseline; "~p < 0.05 versus baseline at 
PRE-BYPASS. Values shown as mean plus or minus 
standard error of mean. 
Table I. ATP concentrations of coronary arterial 
smooth muscle and myocardium 
Prebypass Postcardioplegia Postreperfusion 
(n =4) (n = 4) (n = 4) 
87 - 23 25 _+ 2* 29 -+ 4* Coronary arterial 
smooth muscle 
(/xg/gm wet 
tissue) 
Myocardium 
(tzg/gm wet 
tissue) 
481 --- 95 184 _+ 54* 216 -+ 10" 
Postcardioplegia, After 2 minutes of postcardioplegia reperfusion; pos- 
treperfusion, after 60 minutes of postcardioplegia reperfusion. Mean plus 
or minus standard error of mean. 
*p < 0.05 versus prebypass. 
Results 
Vessel characteristics. At an intraluminal pres- 
sure of 50 mm Hg, coronary microvessels ranged 90 
to 180/xm in internal diameter, averaging 143 _+ 3 
/xm, 152 __ 10/~m, and 135 + 5 p~m in the control, 
cardioplegia, and cardioplegia-reperfusion groups, 
respectively. Percent precontraction after applica- 
tion of acetylcholine was 36% _+ 2%, 37% _+ 2%, 
and 30% _+ 1% in the control, cardioplegia, and 
cardioplegia-reperfusion groups, respectively. Mean 
concentrations of acetylcholine required to obtain 
these percent contractions were 10 -6.4 mol/L, 10 -6.3 
mol/L, and 10 -6.2 mol/L in the control, cardioplegia, 
and cardioplegia-reperfusion groups, respectively. 
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Fig. 2. Changes in coronary blood flow in response to 
intracoronary glibenclamide administration under base- 
line condition (PRE-BYPASS) and after 2 minutes (POST- 
CARDIOPLEGIA, n --- 6) and 60 minutes of reperfusion 
(POST-REPERFUSION, n = 7). **p < 0.01 versus respec- 
tive baseline; tp < 0.05 versus baseline at PRE-BYPASS. 
Values given as mean plus or minus standard error of 
mean. 
Tissue ATP measurements. In control animals, 
ATP concentrations in subepicardial coronary arter- 
ies and myocardial tissues were 87 _+ 23 and 481 _+ 
95 /xg per gram wet tissue, respectively. ATP con- 
centrations in coronary arteries decreased to 25 _+ 2 
/xg per gram wet tissue after cardioplegia nd to 
29 + 4 /~g per gram wet tissue after reperfusion 
(both p < 0.05 versus control). Myocardial concen- 
trations of ATP were reduced to 184 + 54 and 
216 + 10/xg per gram wet tissue after cardioplegia 
and reperfusion, respectively (both p < 0.05 versus 
control) (Table I). 
In vivo response to glibenclamide and pinacidil. 
In vivo responses to intracoronary administration of
glibenclamide and pinacidil are shown in Figs. 1 and 
2 and Tables II and III. Before CPB and cardiople- 
gic arrest, glibenclamide decreased the coronary 
blood flow rate from 7 _+ 1 to 6 _+ 1 ml/min (p = 
0.076) and increased coronary vascular resistance 
from 7 _+ 1 to 13 _+ 2 mm Hg/ml per minute (p = 
0.268), whereas pinacidil increased the coronary 
blood flow rate from 9 _+ 2 to 27 _+ 5 ml/min (p = 
0.005) and decreased coronary vascular resistance 
from 12 + 1 to 3 _+ 1 mm Hg/ml per minute (p = 
0.001). Coronary blood flow increased by 192% of 
the precardioplegia level and coronary vascular e- 
sistance decreased to 4 _+ 1 mm Hg/ml per minute 
(both p < 0.01 versus baseline) 2 minutes after 
The Journal of Thoracic and 
Cardiovascular Surgery 
Volume 110, Number 4, Part 1 
Wang et aL 1077 
Table II. In vivo responses to intracoronary administration of pinacidil (2 Ixg/kg per minute) (n = 7) 
Prebypass Postcardioplegia Postreperfusion 
Baseline Pinacidil Baseline Pinacidil Baseline Pinacidil 
Heart rate (beats/rain) 142 ± 8 145 ± 8 137 ± 7 132 ± 7 144 ± 7 146 ± 7 
LV systolic pressure (mm Hg) 98 ± 3 101 ± 2 95 ± 5 98 ± 5 91 ± 8 92 ± 9 
LV fractional shortening (%) -25 ± 2 -27 ± 2 -18 ± 2* -19 ± 2 -20  ± 2* -20  ± 2 
LV dP/dt (mm Hg/sec) 2800 ± 200 2900 ± 200 2100 ± 200* 2200 ± 200 2000 ± 100" 2100 ± 100 
Coronary blood flow (ml/min) 9 ± 2 27 +_ 5"~ 20 ± 3 40 ± 71 19 ± 4 47 +- 11+ 
Coronary vascular esistance 12 ± 1 3 ± 17 4 ± 1 2 ± i t  4 ± l 2 ± i t  
(mrn Hg/ml/min) 
LV, Left ventricle; posteardioplegia, after 2 minutes of postcardioplegia reperfusion; postreperfusion, after 60 minutes of postcardioplegia reperfusion. Mean 
plus or minus standard error of the mean. 
*p < 0,05 versus baseline at prebypass. 
tp < 0.01. 
~p < 0.05 versus the respective baseline. 
Table III. In vivo responses to intracoronary administration of glibenclamide (50 pg/kg per minute) (n = 7) 
Prebypass Postcardioplegia Postreperfusion 
Baseline Glibenclamide Baseline Glibenclamide Baseline Gfibenclamide 
Heart rate (beats/min) 143 ± 7 141 ± 9 132 ± 8 
LV systolic pressure (mm Hg) 100 ± 3 98 ± 2 96 ± 5 
LV fractional shortening (%) -24  ± 2 -25 ± 3 -19 _+ 2* 
LV dP/dt (mm Hg/sec) 2900 ± 200 2800 ± 200 2100 ± 200* 
Coronary blood flow (ml/min) 7 ± 1 6 ± 1 20 ± 3 
Coronary vascular esistance 7 _ 1 13 ± 2 4 ± 1 
(mrn Hg/ml/min) 
125 ± 7 148 ± 10 143 ± 8 
87 ± 8t 90 ± 7 90 ± 6 
-16 ± 2 -20 ± 2 -19  ± 2 
1800 ± 200 2000 ± 100" 2000 ± 200 
7±2t  19±4 5_+1t 
24 ± 13:~ 4 ± 1 19 ± 6:~ 
LV, Left ventricle; Postcardioplegia, after 2 minutes of postcardioplegia reperfusionzpostreperfusion, after 60 minutes of postcardioplegia reperfusion. Mean 
plus or minus standard error of the mean. 
*p < 0.05 versus baseline at prebypass. 
tp < 0,01. 
Sp < 0,05 versus the respective baseline. 
release of the aortic crossclamp. At the same time, 
glibenclamide decreased the coronary blood flow 
rate from 20 + 3 to 7 _+ 2 ml/min (p = 0.006) and 
increased coronary vascular esistance from 4 + 1 to 
24 + 13 mm Hg/ml per minute (p = 0.049) and 
pinacidil increased the coronary blood flow rate 
from 20 + 3 to 40 _+ 7 ml/min (p = 0.002) and 
decreased coronary vascular esistance from 4 + 1 
to 2 + 1 mm Hg/ml per minute (p = 0.006). After 60 
minutes of postcardioplegia reperfusion, while cor- 
onary blood flow was still 166% of the precardiople- 
gia level (p < 0.05 versus baseline value), gliben- 
clamide and pinacidil caused a respective decrease 
from 19 + 4 to 5 + 1 ml/min (p = 0.009) and an 
increase from 19 +_ 4 to 47 +_ 11 ml/min (p = 0.047) 
in coronary blood flow and an increase from 4 + 1 
to 19 + 6 mm Hg/ml per minute (p = 0.042) and a 
decrease from 4 + i to 2 _+ 1 mm Hg/ml per minute 
(p = 0.006) in coronary vascular esistance. 
Intracoronary administration of glibenclamide or 
pinacidil was not associated with significant alter- 
ations in cardiac functional parameters (Tables II 
and III), except in two animals in which gliben- 
clamide administration after 2 minutes of reperfusion 
decreased left ventricular systolic pressure, fractional 
shortening, and dP/dt. However, changes in these 
cardiac functional parameters were preceded by a 
significant reduction in coronary blood flow. 
In vitro response to pinacidil and glibenelamide. 
Pinacidil induced a significant relaxation response in 
control vessels. The response to pinacidil was en- 
hanced after 2 minutes or 60 minutes of reperfusion 
(both p < 0.05 versus control, Fig. 3). In control 
vessels, glibenclamide induced a 3% + 1% contrac- 
tion. The contractile response to glibenclamide was 
significantly increased to 5% +_ 1% in the cardio- 
plegia group and to 6% -+ 1% in the cardioplegia- 
reperfusion group (both p < 0.05 versus control), 
indicating an increased open-state probability of 
K+ATp channels. 
In vitro response to adenosine. The relaxation 
response to adenosine was significantly decreased 
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Fig. 3. In vitro responses ofprecontracted porcine coro- 
nary microvessels to pinacidil from control animals (n = 
7) and animals after 2 minutes (n = 6) or 60 minutes (n 
= 7) of reperfusion and response of vessels from 
control animals to pinacidil after pretreatment with 
glibenclamide (10 -5 mol/L). Microvessels were pressur- 
ized to 40 mm Hg in no-flow state. Drugs were applied 
extraluminally. Responses are expressed as percent 
relaxation of acetylcholine-induced vascular contrac- 
tion. *p < 0.05; §p < 0.001 versus CONTROL. Values 
given as mean plus or minus standard error of mean. 
CP, Cardioplegia. 
after 2 minutes of reperfusion (p < 0.01 versus 
control). After 60 minutes of reperfusion, however, 
the relaxation response to adenosine was signifi- 
cantly increased above the control evel (p < 0.01 
versus control, Fig. 4). 
In vitro response to sodium nitroprusside. The 
relaxation response to sodium nitroprusside, which 
operates through a cyclic guanosine monophos- 
phate-mediated ndothelium-independent mecha- 
nism, was similar in control, cardioplegia, nd reper- 
fusion groups. The response was 76% __ 6% (10 -5 
mol/L), 76% __ 4% (10 -5 tool/L), and 78% -+ 5% 
(10 -5 mol/L) in the control, cardioplegia, nd reper- 
fusion groups, respectively. 
In vitro effects of glibenclamide on relaxation 
responses to pinacidil and adenosine. In control 
vessels, pretreatment with glibenclamide signifi- 
cantly attenuated the relaxation response to pinaci- 
dil (p < 0.01 versus vessels without glibenclamide, 
Fig. 3). In control vessels pretreated with gliben- 
clamide (10 -5 mol/L), the relaxation response to 
adenosine was diminished (p < 0.01 versus that in 
vessels without glibenclamide, Fig. 4) but to a lesser 
degree compared with the response to pinacidil. 
This indicates that activation of K+ATP channels was 
involved only partially in the adenosine-induced 
relaxation of coronary microvessels. 
Discussion 
The present study provides evidence that reactive 
coronary hyperemia ssociated with postischemic 
cardioplegia s mediated, at least in part, by activa- 
tion of K+ATP channels. Under baseline conditions, 
blockade of K+ATP channels with glibenclamide 
decreased coronary blood flow by only 9%. Imme- 
diately after removal of the aortic crossclamp and 
initiation of myocardial perfusion, there was a 
prompt and sustained (up to 60 minutes) increase in 
coronary blood flow. Subsequent administrations of 
glibenclamide r sulted in respective 66% and 72% 
decreases in coronary blood flow 2 minutes and 60 
minutes after reperfusion. These in vivo findings 
were consistent with in vitro observations that 
showed that the relaxation response to the K+ATP 
channel opener pinacidil and the contractile re- 
sponse to the K+ATP channel blocker glibenclamide 
were markedly enhanced after cardioplegia, which 
suggests an increased open-state probability of the 
K+ATP channel. Thus the present study demon- 
strates that activation of K+ATP channels i a mech- 
anism underlying the coronary hyperemia. It was 
noteworthy that glibenclamide significantly attenu- 
ated but did not completely abolish coronary hy- 
peremia and that pinacidil increased established 
coronary hyperemia. Thus mechanisms other than 
activation of K+ATP channels are also involved in 
postcardioplegic hyperemia. It is possible that the 
primary mediator of the hyperemic response may be 
activation of K+ATP channels because of reduced 
tissue concentration of ATP. However, impaired 
myogenic ontraction 5' 6, 14 and the flow-mediated 
release of nitric oxide undoubtedly contribute sig- 
nificantly to an additional increase in coronary 
vasodilation. 7 
Since the K+ATP channel was first described by 
Noma 15 in cardiac myocytes, this channel has been 
identified in the pancreatic/3 cell, 16 central nervous 
system, 17 skeletal muscle, TM and vascular smooth 
muscle. 19 A previous tudy has shown that K+ATP 
channels mediate coronary hyperemia fter brief 
coronary occlusion. 8 Furthermore, a substantial 
base of evidence has suggested that coronary and 
cerebral vasodilation elicited by hypoxia is signifi- 
cantly attenuated by glibenclamide. 1' 3, 20 In canine 
hearts, increases in coronary blood flow in response 
to a reduction in perfusion pressure or during 
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exercise were prevented after blockade of K+ATp 
channels. 21-23 Similarly, activation of K÷ATP chan- 
nels on exposure to hypoxia was shown in the 
isolated canine diaphragm, 24 renal afferent arte- 
rioles of rats, 4 and the isolated ferret lung. 25 The 
opening of these channels i likely caused by reduc- 
tion in the cytosolic ATP concentration because 
K+ATP channels are inactivated in the presence of 
physiologic oncentrations of intracellular ATP. In 
the isolated heart of guinea pigs, Duat and associ- 
ates 1compared the effects of hypoxia with applica- 
tion of the mitochondrial uncoupler, 2,4-dinitrophe- 
nol, and observed similar coronary responses to 
both interventions. Electrophysiologic evidence ob- 
tained with the use of the patch-clamp technique has 
also demonstrated that these channels can be di- 
rectly activated in response to a reduction in intra- 
cellular ATP. 26 Of related interest, hyperglycemia is 
reported to diminish the K+ATP channel-associated 
vasodilation i the pulmonary circulation. 25
Previous studies have suggested the correlation 
between activation of K+ATP channels and hypoxia 
or ischemia, or both; however, effects of ischemic 
crystalloid cardioplegia on K÷ATP channels, espe- 
cially in the coronary microcirculation, have not 
been elucidated. During cardioplegic arrest, the 
myocardium is deprived of its native blood flow and 
energy is derived primarily from the anaerobic me- 
tabolism. Despite a low basal oxygen consumption 
in vascular smooth muscle, its intracellular concen- 
tration of ATP was markedly decreased after brief 
coronary occlusion likely because of the lack of ATP 
and phosphocreatinine i  this tissue. 27 Moreover, 
because intracellular ATP can be compartmental- 
ized, a local decrease in the ATP production ear 
the inner surface of the plasma membrane may also 
regulate these channels. 28 In the present s udy, 
decreases in ATP concentrations in the coronary 
artery wall and in the myocardial tissue were ob- 
served 2 minutes after reperfusion and persisted for 
up to 60 minutes of reperfusion. We obtained vessel 
specimens from the distal LAD coronary artery. It 
was unlikely, however, that the arteriolar smooth 
muscle metabolism would differ significantly from 
that of the large distal branches of the epicardial 
arteries. A previous finding showed a decreased 
ATP concentration i human myocardial tissues 
harvested before termination of crystalloid cardio- 
plegia and 30 minutes after postcardioplegia reper- 
fusion. 29 It has been suggested that metabolic 
changes in cardiac myocytes could alter the open- 
state probability of K+ATP channels in vascular 
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Fig. 4. In vitro responses of precontracted porcine coro- 
nary microvessels to adenosine from control animals (n = 
7) and animals after 2 minutes (n = 6) or 60 minutes (n = 
7) of reperfusion and response f v ssels from control 
animals to adenosine after pretreatment with gliben- 
clamide (10 -5 mol/L). Microvessels were pressurized to 
40 mm Hg in no-flow state. Drugs were applied extralu- 
minally. Responses are expressed as percent relaxation 
of acetylcholine-induced vascular contraction. **p < 
0.01; §p < 0.001 versus CONTROL. Values given as 
mean plus or minus standard error f mean. CP, 
Cardioplegia. 
smooth muscles because the oxygen concentration 
in the myocardium may function as a signal regulat- 
ing the generation of ATP in vascular smooth 
muscle. 9 In addition, some metabolites released 
from ischemic tissues may contribute to the regula- 
tion of K+ATP channels. Indeed, a recent study has 
indicated a role of lactate in activation of K+ATP 
channels in cardiac myocytes of guinea pigs. 3° 
In the present study, glibenclamide atthe dosage 
of 50 /xg/kg per minute caused a 9% decrease in 
basal coronary blood flow, suggesting a role of 
K+ATP channels in the maintenance of basal coro- 
nary vascular tone. The coronary response to glib- 
enclamide contrasts with that in reports that found 
20% to 50% decreases in coronary blood flow in 
response to similar concentrations of glibenclamide 
in canine hearts. 23'31'32 Results of other studies 
were, however, consistent with our findings that 
K÷ATP channels contributed minimally to basal vas- 
cular tone. 2' 3, 9 A previous in vitro study demon- 
strated that K+ATp channels are inactivated when 
the intracellular concentration f ATP is more than 
1 mmol/L. Therefore, under physiologic onditions, 
most K+ATP channels appear to have already been 
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inhibited, and glibenclamide would not be expected 
to reduce basal blood flow. The reason for the 
discrepancy in the glibenclamide-induced hange in 
basal blood flow obtained from different studies 
remains unclear. It was possible that a higher level 
of intracellular ATP might be required in the in vivo 
setting to achieve an inhibitory effect on K+ATe 
channels compared with that under in vitro condi- 
tions. 31 Furthermore, factors (i.e., lactate) other 
than ATP may also contribute to the regulation of 
opening of K+ATP channels. 3°In addition, it is also 
plausible that the difference in the basal vascular 
tone may account for the different magnitude of 
changes in coronary blood flow in response to 
glibenclamide administration. 
We observed that the relaxation response to 
adenosine was, somewhat unexpectedly, blunted im- 
mediately after cardioplegic arrest but was en- 
hanced to higher than the control evel after reper- 
fusion. Adenosine is thought o be a mediator of 
coronary hyperemia because it is released uring 
hypoxia or ischemia, or both. However, its signifi- 
cant role in the genesis of hyperemic response was 
challenged by a study of Saito and colleagues 33that 
showed that adenosine accounted for no more than 
30% of the coronary hyperemic response. Adeno- 
sine is known as a coronary vasodilator that may act 
through several different mechanisms. It was sug- 
gested that adenosine might induce an endothelium- 
dependent relaxation. 34 Because nitric oxide, an 
endothelium-derived relaxing factor, has been 
shown to regulate coronary blood flow during reac- 
tive hyperemia, 7 adenosine might induce coronary 
hyperemia by the release of the endothelium-de- 
rived relaxing factor. However, previous investiga- 
tions have demonstrated that N~-monomethyl-I. - 
arginine (a nitric oxide synthase inhibitor) does not 
significantly alter the relaxation response of coro- 
nary microvessels toadenosine. 35' 36 In addition, our 
previous tudies have shown a progressive deterio- 
ration of the endothelial function in the coronary 
microcirculation after postcardioplegia reperfu- 
sion,37.38 whereas the relaxation response to aden- 
osine was completely recovered after 60 minutes of 
reperfusion. Thus it was unlikely that adenosine 
induced coronary vasodilation primarily through 
the endothelium-dependent mechanism. Recently, 
adenosine has been shown to relax vascular smooth 
muscles by activating K+ATP channels. However, we 
and others 35" 36 showed that the relaxation response 
to adenosine was only partially inhibited by gliben- 
clamide. Similarly, in cerebral arterioles of rabbits 
the adenosine-induced vasodilation was only slightly 
affected by glibenclamide. 3 In the present study, 
although responses to glibenclamide and pinacidil 
were increased immediately after cardioplegia, the 
relaxation to adenosine was decreased. This sug- 
gests that factors other than K+ATP channels con- 
tribute to the vasodilatory effect of adenosine. It is 
important o note that adenosine may increase 
intracellular cyclic adenosine monophosphate con- 
centration by stimulating adenylate cyclase in the 
coronary vascular smooth muscle. 39 We have previ- 
ously demonstrated that the relaxation response of 
coronary microvessels to forskolin (an adenylate 
cyclase activator) is reduced 2 minutes after reper- 
fusion but is increased above the control level 60 
minutes after reperfusion. 6 Thus the down- and 
up-regulation of the adenylate cyclase activity in- 
duced by respective ischemia-cardioplegia and 
reperfusion was comparable with characteristic 
changes in the response to adenosine observed in 
the present study. This suggests that adenosine 
appears to relax porcine coronary microvessels pri- 
marily by activation of adenylate cyclase. Because 
the relaxation response to adenosine was increased 
60 minutes after reperfusion, adenosine might play 
in part a role in the late phase of postcardioplegia 
hyperemia. This assumption appears to support he 
hypothesis that adenosine released from ischemic 
tissues may be involved in determining the duration 
of reactive hyperemic response. 4°
A decreased cardiac systolic function was ob- 
served in two animals during intracoronary admin- 
istration of glibenclamide after cardioplegic arrest. 
It was unlikely that alteration in cardiac systolic 
function was caused by a direct effect of gliben- 
clamide because this negative inotropic effect was 
preceded by a significant reduction in coronary 
blood flow. This observation was in agreement with 
the finding of Duncker and associates, 23 which 
showed that the glibenclamide-induced myocardial 
dysfunction was restored when the rate of coronary 
blood flow was returned to the baseline level with 
sodium nitroprusside. Thus glibenclamide may 
elicit coronary vasoconstriction a d lead second- 
arily to ischemic myocardial dysfunction. This glib- 
enclamide-induced effect may be particularly impor- 
tant in the heart subjected to hypoxia or ischemia, or 
both, in that under such conditions coronary vessels 
may be hyperactive to K+ATP blockers because of an 
increased probability of opening of these channels. 
In the present study, hyperkalemic ischemia-car- 
dioplegia was associated with a 192% increase in 
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coronary blood flow. Coronary reactive hyperemia 
can be elicited by a coronary occlusion as brief as 
200 msec and the coronary blood flow may increase 
to 300% to 600% of the occlusion debt. 41 The role 
of coronary hyperemia in the preservation of cardiac 
function has been suggested in previous investiga- 
tions. Although the possible explanation for this 
phenomenon remains unclear, it may include the 
improved removal of metabolites (e.g., H ÷ or lac- 
tate) as result of an increased coronary blood flow. 
Schwartz and colleagues 42showed that limitation of 
peak reactive hyperemic oronary blood flow by 
epicardial coronary constriction delayed metabolic 
and functional recovery of the myocardium after 
brief myocardial ischemia. Furthermore, the corre- 
lations between the extent of hyperemia nd re- 
covery of left ventricular function and myocardial 
necrosis were postulated by Heyndrickx and associ- 
ates 43 and Cobb and associates. 44In addition, brief 
coronary occlusion has been occasionally done in- 
traoperatively to assess coronary reserve capacity. 
The presence of the viable myocardium was indi- 
cated by a normal hyperemic response. Thus it 
appears that coronary hyperemia ssociated with 
activation of K+ATP channels may be of positive 
predictive value with respect o recovery of cardiac 
function after cardiac operation. However, excessive 
and persistent coronary hyperemia could result in 
detrimental effects (for example, tissue edema) on 
the heart. Moreover, a previous study reported an 
increased risk of cardiovascular mortality in diabetes 
mellitus by administration of K+ATP channel block- 
ers. 45 Thus it remains to be determined whether in 
patients with diabetes the administration of antidi- 
abetic sulfonylureas (e.g., glibenclamide) should be 
continued or discontinued before cardiac opera- 
tions. 
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